Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 9

1.

Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment.

Nardi V, Sadow PM, Juric D, Zhao D, Cosper AK, Bergethon K, Scialabba VL, Batten JM, Borger DR, Iafrate AJ, Heist RS, Lawrence DP, Flaherty KT, Bendell JC, Deschler D, Li Y, Wirth LJ, Dias-Santagata D.

Clin Cancer Res. 2013 Jan 15;19(2):480-90. doi: 10.1158/1078-0432.CCR-12-1842. Epub 2012 Nov 27.

2.

[Salivary duct carcinoma].

Hungermann D, Roeser K, Buerger H, Jäkel T, Löning T, Herbst H.

Pathologe. 2005 Sep;26(5):353-8. Review. German.

PMID:
16041504
3.

Targeted therapy with trastuzumab for advanced salivary ductal carcinoma: case report and literature review.

Kaidar-Person O, Billan S, Kuten A.

Med Oncol. 2012 Jun;29(2):704-6. doi: 10.1007/s12032-011-9884-1. Epub 2011 Mar 6. Review.

PMID:
21380780
4.

Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer.

Siena S, Sartore-Bianchi A, Di Nicolantonio F, Balfour J, Bardelli A.

J Natl Cancer Inst. 2009 Oct 7;101(19):1308-24. doi: 10.1093/jnci/djp280. Epub 2009 Sep 8. Review.

5.

Human Epidermal Growth Factor Receptor 2 (HER2/neu) in Salivary Gland Carcinomas: A Review of Literature.

Alotaibi AM, Alqarni MA, Alnobi A, Tarakji B.

J Clin Diagn Res. 2015 Feb;9(2):ZE04-8. doi: 10.7860/JCDR/2015/11289.5572. Epub 2015 Feb 1. Review.

6.

Salivary Gland Cancers: Biology and Systemic Therapy.

Goyal G, Mehdi SA, Ganti AK.

Oncology (Williston Park). 2015 Oct;29(10):773-80. Review.

7.

Targeted therapies and clinical trials in ovarian cancer.

Dancey J.

Ann Oncol. 2013 Dec;24 Suppl 10:x59-x63. doi: 10.1093/annonc/mdt473. Review.

8.

Systemic therapy in the management of metastatic or advanced salivary gland cancers.

Lagha A, Chraiet N, Ayadi M, Krimi S, Allani B, Rifi H, Raies H, Mezlini A.

Oral Oncol. 2012 Oct;48(10):948-57. doi: 10.1016/j.oraloncology.2012.05.004. Epub 2012 Jun 12. Review.

PMID:
22698431
9.

New agents in the treatment for malignancies of the salivary and thyroid glands.

Mehra R, Cohen RB.

Hematol Oncol Clin North Am. 2008 Dec;22(6):1279-95, xi. doi: 10.1016/j.hoc.2008.08.010. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk